T J Matthews

Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes.

Jason B. Weinberg, T J Matthews, Bryan R. Cullen et al. · The Journal of Experimental Medicine · 1991 · 357 citations · Full text

Viral Replication, Cellular Dna Synthesis, Immunology +16

Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack.

H. Kim Lyerly, T J Matthews, A J Langlois et al. · Proceedings of the National Academy of Sciences · 1987 · 216 citations · Full text

Immunology, Pathology, Immunologic Mechanism +20

A Dose-Ranging Study of a Prototype Synthetic HIV-1MN V3 Branched Peptide Vaccine

Geoffrey J. Gorse, M. C. Keefer, Robert B. Belshe et al. · The Journal of Infectious Diseases · 1996 · 67 citations

Vaccination, Mn Strain, Vaccine Development +13

Binding site for human immunodeficiency virus coat protein gp120 is located in the NH2-terminal region of T4 (CD4) and requires the intact variable-region-like domain.

Neil Richardson, Nick R. Brown, Rebecca E. Hussey et al. · Proceedings of the National Academy of Sciences · 1988 · 57 citations · Full text

Virus Structure, Viral Replication, Human Retrovirus +15

Expression and immunogenicity of the extracellular domain of the human immunodeficiency virus type 1 envelope glycoprotein, gp160

Phillip W. Berman, L Riddle, Gerald Nakamura et al. · Journal of Virology · 1989 · 42 citations · Full text

Extracellular Domain, Synthetic Virology, Glycobiology +17